Clinical Trials Directory

Trials / Completed

CompletedNCT01748734

Cognitive Therapy in Reducing Depression in Patients With Cancer

An Examination of Cognitive Therapy for Depression in Cancer Patients.

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
25 (actual)
Sponsor
Ohio State University Comprehensive Cancer Center · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to learn about treatment of depression in people who have any type of cancer. Cognitive therapy (CT) helps improve depressive symptoms by targeting patient's thoughts and behaviors. People who are depressed tend to have more negative or pessimistic thoughts. CT helps people evaluate the accuracy of their thoughts. By encouraging patients to develop more balanced views, symptoms of depression begin to improve

Detailed description

PRIMARY OBJECTIVES: I. Determine the efficacy of biobehavioral/cognitive therapy for cancer patients/survivors with major depression. II. Test for the covariation between reduction in depressive symptoms and improvements in quality of life. OUTLINE: Patients undergo cognitive behavioral therapy comprising progressive muscle relaxation training, behavioral activation, seeking information as a coping strategy, enhancing social support, cognitive reappraisal, assertive communication, changing depressive core beliefs, goal setting and planning for maintenance, and maintenance over 1 hour once weekly sessions for 12-20 weeks, biweekly sessions for 4-6 weeks, and monthly sessions for 2-3 months for a total of 16-26 sessions. After completion of study treatment, patients are followed up at 3, 6, and 12 months.

Conditions

Interventions

TypeNameDescription
PROCEDUREquality-of-life assessmentAncillary studies
OTHERquestionnaire administrationAncillary studies
OTHERcounseling interventionUndergo cognitive behavioral therapy
BEHAVIORALbehavioral interventionUndergo cognitive behavioral therapy

Timeline

Start date
2011-03-01
Primary completion
2011-03-01
First posted
2012-12-12
Last updated
2015-06-04

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01748734. Inclusion in this directory is not an endorsement.